de Isla, LP, Vallejo-Vaz, AJ, Watts, GF, Muñiz-Grijalvo, O, Alonso, R, Diaz-Diaz, JL, Arroyo-Olivares, R, Aguado, R, Argueso, R, Mauri, M, Romero, MJ, Alvarez-Baños, P, Mañas, D, Cepeda, JM, Gonzalez-Bustos, P, Casañas, M, Michan, A, Muñoz-Torrero, JFS, Faedo, C, Barba, MA, Dieguez, M, de Andrés, R, Hernandez, AM, Gonzalez-Estrada, A, Padró, T, Fuentes, F, Badimon, L, Mata, P. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study. Lancet Diabetes & Endocrinology. 2024; 12(9)DOI:10.1016/S2213-8587(24)00192-X. PMID:39098315. IF:41.800(Q1/1D).

Fernandez-Bravo, S, Canyelles, M, Martín-Blázquez, A, Borràs, C, Nuñez-Borque, E, Palacio-García, L, Del Rio, PR, Betancor, D, Gómez-López, A, Brescó, MS, Laguna, JJ, Méndez-Barbero, N, Rotllan, N, Escolà-Gil, JC, Esteban, V. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(3)DOI:10.1016/j.jaci.2024.03.031. PMID:38718948. IF:11.200(Q1/1D).

Agulló, GJ, Aragon, MP, de la Poza, JFD, Alcorisa, SV. Serum calprotectin in severe and mild COVID-19 patients. EUROPEAN JOURNAL OF IMMUNOLOGY. 2024; 54DOI:. PMID:. IF:3.700(Q2/5D).

Somolinos-Simón, FJ, García-Sáez, G, Tapia-Galisteo, J, Corcoy, R, Hernando, ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 215DOI:10.1016/j.diabres.2024.111803. PMID:39089589. IF:7.400(Q1/1D).

Cheng, A, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, M, Bonnemaire, M, Lydie, MM, Mimouni, S, Davies, M. Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Claramunt, FC, Lazaro, D, Salter, J, Paldánius, P, Mauricio, D. Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Torre, ELM, Alarcón, PP, Rodríguez, MM, Serrallonga, NB, Palomar, JR, Iglesias, DM, Hoyas, CN, Servat, OS, Kyriakos, G, Bellas, LC, Pla, RC, Ramonde, TM, López, ML, Madorell, BS, Borrás, JG. Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).